Literature DB >> 2938073

Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.

A J Groeneveld, J R Brouwers.   

Abstract

A simple sensitive HPLC method for the analysis of ciprofloxacin, norfloxacin, ofloxacin and pefloxacin in serum is described. The quinolones were extracted using dichloromethane under neutral conditions, followed by drying under nitrogen and dissolving in mobile phase before chromatographic analysis. The stationary phase consisted of a stainless steel column with Nucleosil CI8 (5 microns), and a mobile phase of 0.04 M phosphoric acid, tetrabutylammoniumiodide as ion-pairing reagent and methanol (pH 2.2). UV absorbance was used for detection. The method was shown to be linear, quantitative and reproducible in the therapeutic range of each of these quinolones. Serum levels of ofloxacin and ciprofloxacin were determined and compared to those found by a microbiological assay. Good correlation was found for the assay of ciprofloxacin as well as for ofloxacin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938073     DOI: 10.1007/bf01975486

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  9 in total

1.  Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.

Authors:  G Montay; J P Tassel
Journal:  J Chromatogr       Date:  1985-04-12

2.  Reversed phase ion pair chromatography with an adsorbing stationary phase and a hydrophobic quaternary ammonium ion in the mobile phase. Part II: quantitative analysis of multi-component analgesic pharmaceutical preparations.

Authors:  A Tilly Melin; Y Askemark
Journal:  Acta Pharm Suec       Date:  1979

3.  Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.

Authors:  J A Hoogkamp-Korstanje; H J van Oort; J J Schipper; T van der Wal
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

4.  Multiple-dose ciprofloxacin kinetics in normal subjects.

Authors:  G E Aronoff; C H Kenner; R S Sloan; S T Pottratz
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

5.  Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.

Authors:  M Eandi; I Viano; F Di Nola; L Leone; E Genazzani
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

6.  Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography.

Authors:  L T Pauliukonis; D G Musson; W F Bayne
Journal:  J Pharm Sci       Date:  1984-01       Impact factor: 3.534

7.  Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography.

Authors:  A Weber; D Chaffin; A Smith; K E Opheim
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.

Authors:  M Wolff; B Regnier; C Daldoss; M Nkam; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

9.  Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.

Authors:  V K Boppana; B N Swanson
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

  9 in total
  4 in total

Review 1.  Pharmacokinetics of the newer fluoroquinolones.

Authors:  J R Brouwers
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

2.  Decreased ciprofloxacin absorption with concomitant administration of ferrous fumarate.

Authors:  J R Brouwers; H J Van der Kam; J Sijtsma; J H Proost
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

3.  Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally.

Authors:  N Bitar; R Claes; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

4.  A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.

Authors:  L O White; A P MacGowan; A M Lovering; D S Reeves; I G Mackay
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.